Clincosm LogoSign in Get a demo

Metastatic Non Small Cell Lung Cancer

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Metastatic Non Small Cell Lung Cancer, KRAS G12C Trial in Worldwide (Sotorasib, Lenvatinib)

Not yet recruiting
  • Metastatic Non Small Cell Lung Cancer
  • KRAS G12C
  • Innsbruck, Austria
  • +14 more
Sep 28, 2023

Metastatic Non Small Cell Lung Cancer Trial in Japan (Datopotamab Deruxtecan, Pembrolizumab, Pemetrexed)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Datopotamab Deruxtecan
  • +4 more
  • Fukuoka, Japan
  • +3 more
Jan 13, 2023

Metastatic Non Small Cell Lung Cancer Trial in Raleigh (C-TIL051)

Not yet recruiting
  • Metastatic Non Small Cell Lung Cancer
  • C-TIL051
  • Raleigh, North Carolina
    Duke Cancer Institute
Jan 6, 2023

Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab/Vibostolimab coformuation, Docetaxel, Placebo)

Active, not recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Pembrolizumab/Vibostolimab coformuation
  • +2 more
  • Los Angeles, California
  • +94 more
Jan 4, 2023

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Metastatic Non Small Cell Lung Cancer Trial in Australia, Singapore (Osimertinib, Stereotactic Radiosurgery (SRS))

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Newcastle, New South Wales, Australia
  • +12 more
Nov 16, 2022

Metastatic Non Small Cell Lung Cancer Trial in Canada, Netherlands, United States (LN-145)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • LN-145
  • Duarte, California
  • +40 more
Oct 20, 2022

Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Datopotamab Deruxtecan, Pembrolizumab)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Chandler, Arizona
  • +32 more
Aug 12, 2022

Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer Trial in Worldwide (MRTX849, Docetaxel)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Advanced Non Small Cell Lung Cancer
  • Santa Rosa, California
  • +141 more
Aug 10, 2022

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Core needle biopsy
  • Madison, Wisconsin
    Elephas
Aug 4, 2022

Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in United States (Amivantamab, Lazertinib)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 1, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess

Recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Local ablative therapy
  • Blood collection to assess for ctDNA
  • Basking Ridge, New Jersey
  • +6 more
Jun 20, 2022

Lorlatinib in ALK/ROS1 Metastatic NSCLC Compassionate Use

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +24 more
Jun 1, 2022

Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer Trial in France (SRT, Immunotherapy)

Recruiting
  • Locally Advanced Non Small Cell Lung Cancer
  • Metastatic Non Small Cell Lung Cancer
  • Angers, France
  • +4 more
Apr 21, 2022

Metastatic Non Small Cell Lung Cancer Trial in Singapore (Nivolumab, ADG106)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Singapore, Singapore
  • +1 more
Mar 10, 2022

Oligometastatic Disease, Metastatic Non Small Cell Lung Cancer Trial in Mumbai (Local consolidative radiation therapy, Standard

Recruiting
  • Oligometastatic Disease
  • Metastatic Non Small Cell Lung Cancer
  • Local consolidative radiation therapy
  • Standard maintenance therapy as decided by the treating medical oncologist
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital, Parel
Mar 11, 2022

Metastatic Non Small Cell Lung Cancer Trial in Italy (Tedopi, Nivolumab, Docetaxel)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Meldola, Forlì, Italy
  • +11 more
Feb 9, 2022

Metastatic Non Small Cell Lung Cancer Trial in India (Dacomitinib)

Active, not recruiting
  • Metastatic Non Small Cell Lung Cancer
  • New Delhi, Delhi, India
  • +13 more
Jan 20, 2022

Pralsetinib to Best Available Therapy in RET-Fusion Positive

Enrolling by invitation
  • RET-fusion Non Small Cell Lung Cancer
  • +16 more
    • New York, New York
    • +2 more
    Aug 9, 2021

    Metastatic Non Small Cell Lung Cancer Trial in Nicosia (Pembrolizumab)

    Unknown status
    • Metastatic Non Small Cell Lung Cancer
    • Nicosia, Strovolos, Cyprus
      Bank of Cyprus Oncology Centre
    Jan 26, 2021

    Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in Philadelphia (Etirinotecan pegol

    Completed
    Has Results
    • Metastatic Non Small Cell Lung Cancer
    • Recurrent Non Small Cell Lung Cancer
    • Etirinotecan pegol (NKTR-102)
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Apr 1, 2020

    Metastatic Non Small Cell Lung Cancer, Metastatic Breast Cancer Trial in Chicago (Pazopanib, Vinorelbine)

    Terminated
    • Metastatic Non Small Cell Lung Cancer
    • Metastatic Breast Cancer
    • Chicago, Illinois
      Northwestern University, Northwestern Medical Faculty Foundation
    Oct 28, 2013